ClinicalTrials.gg
RecruitingNCT04897347Updated Dec 22, 2023

Robotic TruST-Postural Intervention for Children With Cerebral Palsy

An interventional study of Robotic Trunk-Support-Trainer (TruST) and Static Trunk Support in Cerebral Palsy, sponsored by Teachers College, Columbia University. Recruiting at 2 sites in United States. Open to participants aged 6 Years to 17 Years. Per ClinicalTrials.gov, last updated 2023-12-22.

Sponsored by Teachers College, Columbia University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Feb 2022; still recruiting 4 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
82
Allocation
Randomized
Ages
6 Years to 17 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 372 studies in Cerebral Palsy with a site in United States — 74 open to participants now, 102 under way, none of them phase 3. Cerebral Palsy · United States.

Planned enrollment
39th of 296
82 · median 25
Started
2022
with 24 others
No phase
218 of 372
49 open now
Primary completion
2026-12
later than 36 of 101 live
Registered
231st of 372
by date

Among the 372 studies in Cerebral Palsy with a site in United States, this one is the 39th largest by planned enrollment of the 296 interventional ones that give a count, is one of 25 that started in 2022, is one of 218 with no phase, reaches primary completion later than 36 of the 101 other live ones, and was the 231st registered.

Cerebral Palsy

1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

74 of the 372 studies in Cerebral Palsy with a site in United States are open now. Recruiting first, the newest first:

69 more — sign in →

All 74 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.

This study: 6 Years to 17 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 372 studies in Cerebral Palsy with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to test the efficacy of a motor learning-based postural and reaching control intervention delivered with the robotic Trunk-Support-Trainer (TruST) compared to the same motor learning-based intervention delivered with Static Trunk Support Equipment in children with cerebral palsy (CP) classified as III and IV with the Gross Motor Function Classification System (GMFCS).

Read the detailed description

This study is a prospective Clinical Randomized Control Trial (RCT) in a group of 82 children with cerebral palsy. The experimental and control groups will receive effective postural-reaching training based on motor learning and control principles. In both groups, participants will engage in play and functional activities that elicit arm movement and challenge trunk postural control, and the motor tasks and activities will be progressed. The main difference is that the experimental group will be trained with TruST in order to add postural task-progression via assistive force fields; which will be tailored to the child's sitting control balance status across training sessions. However, in the control group, postural task-progression will be addressed by lowering the level of rigid trunk support segment by segment across training sessions. The trunk subregion where the support is placed will depend on the child's trunk control ability. Participants will be recruited from the United States.

03

Conditions studied

  • Cerebral Palsy

Browse trials for

Keywords

  • Posture
  • Reaching
  • Robotics
  • Motor Learning
  • Motor Control
04

Who can participate

Ages eligible
6 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 6-17 years
  • Diagnosis of Bilateral CP: diplegia, triplegia, or quadriplegia
  • Gross Motor Function Classification Systems-Expanded \& Review (GMFCS) levels III or IV
  • Ability to sit 5s with trunk support between mid-ribs and pelvis (SATCo = 3-7)
  • Cognitive capacity to follow basic verbal instructions (i.e., "do not put your hands on your lap" or "follow and reach the toy")

Exclusion criteria

Exclusion Criteria:

  • Absent head control (SATCo = 1)
  • Current medical illness unrelated to CP at the time of the study
  • Severe dyskinesia that prevents the child from maintaining sitting and recovering balance during reaching movements
  • History of recurrent seizures (daily) or drug-resistance epilepsy
  • Severe Spinal Deformities: scoliosis >40◦ and/or kyphosis >45◦
  • Spinal osteosynthesis or orthopedic surgery of spine, upper or lower extremities in the last 6 months
  • Severe spasticity of biceps/triceps in both upper extremities (Modified Ashworth Scale = 4)
  • Local chemodenervation therapy in spastic muscles (e.g., botulinum toxin or phenol injections) in upper or lower extremities in the previous 3 months or planned during the study
  • Other major surgeries in the previous 6 months (if medically )
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
82 participants (estimated)

Study arms

  • Experimental
    Robotic Trunk-Support-Trainer (TruST)

    Postural-reaching control intervention with TruST

    Device: Robotic Trunk-Support-Trainer (TruST)

  • Active comparator
    Static Trunk Support

    Postural-reaching control intervention with Rigid Trunk Support

    Device: Static Trunk Support

Interventions

  • DeviceRobotic Trunk-Support-Trainer (TruST)

    This will involve tailoring the level of postural assistance via force fields and systematically introduce postural task-progression across training sessions. Age-appropriate activities, including toys and games, will be used in training. - Twelve 2hr training sessions (3 times per week for 4 weeks)

  • DeviceStatic Trunk Support

    This will involve static support for the trunk via a trained therapist. Age-appropriate activities, including toys and games, will be used in training. - Twelve 2hr training sessions (3 times per week for 4 weeks)

06

What researchers measure

Primary outcomes

  1. Change in Modified Functional Reach Test (mFRT) after intervention

    The mFRT measures proactive postural control during maximum reaching distance. It is a valid and reliable tool in CP; and it discriminates GMFCS levels.

    Time frame: Through study completion, an average of 4 months

  2. Change in Postural Star-Sitting Test (PSST) after intervention

    The PSST will be performed before and after interventions to monitor sitting control progression in both TruST- and control-intervention groups. The investigators have several motivations that rationalize this customized measurement. It: 1) is age-appropriate, 2) is goal-oriented, 3) directly measures sitting based on trunk control improvements, 4) is responsive to capture sitting workspace area increases, and 5) offers data with a straightforward functional interpretation.

    Time frame: Through study completion, an average of 4 months

  3. Change in Box and Blocks Test (BBT) after intervention

    The BBT examines manual dexterity. The child moves the maximum number of blocks (2.5cm2), one at a time, between the compartments of a partitioned box within 60s. B\&B is sensitive to post-intervention changes with the more- and less-affected hand. Arm displacement and grasping will be analyzed with Datavyu. An instruction manual has been created to standardize video-coding procedures and define the reaching variables. Grasping will be defined from the moment the hand contacts the block to the time this is lifted from the surface. Arm displacement will be defined from end of grasping to block release. Reaching performance will be the summation of grasping and arm displacement. Two coders will be used to determine video-coding reliability.

    Time frame: Through study completion, an average of 4 months

Secondary outcomes

  1. Change in Gross Motor Function Measure-Item Set (GMFM-IS) after intervention

    The GMFM-IS determines the gross motor function of children with CP-A: lying and rolling, B: sitting, C: crawling, D: standing and E: walking, running \& jumping. It is an abbreviated and validated version of the GMFM-66. It includes an algorithm with three critical items to decide which one of four item sets is most appropriate to assess motor function and obtain a GMFM-66 score. GMFM has been shown to be valid, reliable, and responsive to change in CP. The minimum clinically important difference (MCID) is 0.8-1.6 for medium effect size and 1.3-2.6 for large effect size.

    Time frame: Through study completion, an average of 4 months

  2. Change in Canadian Occupational Performance Measure (COPM) after intervention

    The COPM will be used to investigate perceived parent- and child-based goals, and preferences that are specific to motor impediments in seated posture and reaching abilities that restrict participation. COPM can detect clinical important differences across time and above the MCID of 2 points.

    Time frame: Through study completion, an average of 4 months

  3. Change in Participation and Environment Measure - Children and Youth (PEM-CY) after intervention

    The PEM-CY is a valid and reliable tool to measure participation-home, school and community-including environmental factors. PEM-CY can capture post-intervention changes in each of its dimensions in children with physical disabilities.

    Time frame: Through study completion, an average of 4 months

  4. Change in Seated Postural & Reaching Control (SP&R-co) after intervention

    The theoretical framework, reliability, internal consistency, and construct validity of the SP\&R-co has been validated in CP. It targets children with moderate-to-severe CP within a play-oriented framework. Similar to the SATCo, the SP\&R-co follows a segment-by-segment approach to assess quantitatively sitting control across static, active, proactive (via bimanual and unimanual reaches), and reactive dimensions. Responsiveness has not been addressed, but the standard error measurement of each SP\&R-co dimension are available.

    Time frame: Through study completion, an average of 4 months

  5. Change in Postural and Reaching Kinematics after intervention

    We will follow the seated postural framework validated in the SP\&R-co to capture motor improvements in the next tasks: (1) Static Seated Task: Postural orientation and balance in sitting during 10s. (2) Active Seated Task: Simultaneous control of the trunk and head rotations when the child visually follows an object to the right and left at a 90° angle. (3) Proactive Seated Task: Sitting control via anticipatory and compensatory postural adjustments during direction-specific reaches straight and 45° to the right and left.

    Time frame: Through study completion, an average of 4 months

  6. Change in Segmental Assessment of Trunk Control (SATCo) after intervention

    The SATCo is a valid and reliable test in CP. The evaluator offers support at various trunk segments (shoulders, axillae, inferior angle of scapulae, on lower ribs, below lower ribs, and pelvis) to measure trunk control across 3 dimensions: static (during 5s), proactive (visually following an object), and reactive (postural responses to nudges). The score is from 1 (no head control) to 8 (full trunk control). Test responsiveness has not been established but studies show potential to identify trunk balance improvements in each of the tested trunk segments.

    Time frame: Through study completion, an average of 4 months

07

Study locations

2 of 2 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — All study data will be made available via the Data and Specimen Hub (DASH), a data sharing platform of the Eunice Kennedy Shriver National Institute of Child Health and Development.

Supporting information: Statistical analysis plan

Time frame: Data will be made available upon completion of data collection.

Access criteria: Data will be provided upon request.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2022 (actual). Primary completion is estimated for Dec 2026, 58 months after the start.

Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 58 months is above that.

Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
May 12, 2021
First posted
May 21, 2021
StartActual
Feb 26, 2022
Primary completionEst.
Dec 2026
CompletionEst.
Jun 2027
Last update
Dec 22, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04897347
Lead sponsor
Teachers College, Columbia University
Collaborators
Columbia University
Responsible party
Sponsor
First posted
May 21, 2021
Start date
Feb 26, 2022
Primary completion
Dec 2026 (estimated)
Completion
Jun 2027 (estimated)
Last update
Dec 22, 2023

Study contacts

Victor Santamaria, PT, PhD
Contact
vs2578@columbia.edu
212.678.3332
Karen Chin, MA
Contact
cpresearch@tc.columbia.edu
212.678.3332
Sunil Agrawal, PhD
principal investigator · Columbia University
Andrew Gordon, PhD
principal investigator · Teachers College, Columbia University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion